The effect of infliximab plus methotrexate therapy on the modulation of inflammatory disease markers in patients with early rheumatoid arthritis

被引:0
|
作者
Visvanathan, S
Smolen, J
St Clair, EW
Marini, JC
Pritchard, C
Shergy, W
Joshi, S
Baker, D
Wagner, C
机构
[1] Centocor Inc, Malvern, PA 19355 USA
[2] Univ Vienna, Ctr Rheumat Dis, Vienna, Austria
[3] Lainz Hosp, A-1130 Vienna, Austria
[4] Duke Univ, Dept Med, Div Rheumatol, Durham, NC USA
[5] Rheumat Dis Associates LTD, Rheumatol, Willow Grove, PA USA
[6] Rheumatol Associates N Alabama, Rheumatol, Huntsville, AL USA
[7] Centocor Inc, Outcomes Res, Malvern, PA 19355 USA
[8] Centocor Inc, Clin Res & Dev, Malvern, PA 19355 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:128 / 128
页数:1
相关论文
共 50 条
  • [1] The effect of infliximab plus methotrexate therapy on the modulation of inflammatory disease markers in patients with juvenile rheumatoid arthritis.
    Visvanathan, S
    Marini, JC
    Lovell, D
    Giannini, E
    Ruperto, N
    Martini, A
    Petty, R
    Prieur, AM
    Woo, P
    Travers, SN
    Gathany, T
    Wagner, C
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S86 - S86
  • [2] Modulation of inflammatory disease markers after initiation of infliximab plus methotrexate therapy in patients with juvenile rheumatoid arthritis
    Visvanathan, S.
    Marini, J. C.
    Lovell, D.
    Giannini, E.
    Ruperto, N.
    Martini, A.
    Petty, R.
    Prieur, A.
    Woo, P.
    Travers, S.
    Gathany, T.
    Wagner, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 467 - 468
  • [3] Changes in inflammatory disease markers and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early rheumatoid arthritis.
    Visvanathan, S
    Smolen, J
    St Clair, EW
    Marini, JC
    Pritchard, C
    Shergy, WJ
    Pendley, C
    Joshi, S
    Baker, D
    Wagner, CL
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S396 - S396
  • [4] Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis
    van der Bijl, A. E.
    Goekoop-Ruiterman, Y. P. M.
    de Vries-Bouwstra, J. K.
    ten Wolde, S.
    Han, K. H.
    van Krugten, M. V.
    Allaart, C. F.
    Breedveld, F. C.
    Dijkmans, B. A. C.
    [J]. ARTHRITIS AND RHEUMATISM, 2007, 56 (07): : 2129 - 2134
  • [5] Effect of infliximab and methotrexate on radiographic progression in patients with early rheumatoid arthritis
    van der Heijde, D
    Emery, P
    Keystone, EC
    Maini, RN
    Durez, P
    Kalden, JR
    Schiff, M
    Han, J
    Baker, D
    Smolen, JS
    St Clair, EW
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S139 - S140
  • [6] Effect of infliximab and methotrexate on radiographic progression in patients with early rheumatoid arthritis
    Van der Heijde, D
    Emery, P
    Keystone, E
    Maini, RN
    Durez, P
    Kalden, JR
    Schiff, M
    Han, J
    Baker, D
    Smolen, J
    St Clair, E
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 417 - 417
  • [7] Response to pneumococcal vaccine in patients with, early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone
    Visvanathan, Sudha
    Keenan, Gregory F.
    Baker, Daniel G.
    Levinson, Arnold I.
    Wagner, Carrie L.
    [J]. JOURNAL OF RHEUMATOLOGY, 2007, 34 (05) : 952 - 957
  • [8] The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trial
    Visvanathan, Sudha
    Wagner, Carrie
    Marini, Joseph C.
    Lovell, Daniel J.
    Martini, Alberto
    Petty, Ross
    Cuttica, Ruben
    Woo, Patricia
    Espada, Graciela
    Gattorno, Marco
    Apaz, Maria T.
    Baildam, Eileen
    Fasth, Anders
    Gerloni, Valeria
    Lahdenne, Pekka
    Quartier, Pierre
    Saurenmann, Rotraud
    Travers, Suzanne
    Mendelsohn, Alan
    Xu, Stephen
    Giannini, Edward H.
    Ruperto, Nicoline
    [J]. PEDIATRIC RHEUMATOLOGY, 2010, 8
  • [9] The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trial
    Sudha Visvanathan
    Carrie Wagner
    Joseph C Marini
    Daniel J Lovell
    Alberto Martini
    Ross Petty
    Ruben Cuttica
    Patricia Woo
    Graciela Espada
    Marco Gattorno
    Maria T Apaz
    Eileen Baildam
    Anders Fasth
    Valeria Gerloni
    Pekka Lahdenne
    Pierre Quartier
    Rotraud Saurenmann
    Suzanne Travers
    Alan Mendelsohn
    Stephen Xu
    Edward H Giannini
    Nicolino Ruperto
    [J]. Pediatric Rheumatology, 8
  • [10] The effect of infliximab therapy on the modulation of inflammatory disease markers in patients with ankylosing spondylitis.
    Visvanathan, S
    Marini, JC
    Braun, J
    van der Heijde, D
    Joshi, S
    Williamson, P
    Wagner, CL
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S214 - S214